Intervacc is trading 14.37% down at €0.05; the cause of the decline remains unclear based on supplied price context for October 20, 2026.

  • No clear company-specific announcement explaining the decline was identified; the latest company update found was older.
  • Q3 results are scheduled for November 12.
  • The supplied biotech-sector context is positive, does not align with the decline, and does not explain the move.